Brandon A Mahal

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 13

Top Topics

Prostate Cancer

Randomized Controlled Trial

Radical Prostatectomy

Top Venues

BJU international

This page only lists publications with an associated author ORCID identifier.

Publications

Santino S Butler, Brandon A Mahal, Javid J Moslehi, Anju Nohria, Edward Christopher Dee, Rishi Makkar, Amanda Whitbeck, Janet Wangoe, Kent W Mouw, Paul L Nguyen, Vinayak Muralidhar
Risk of cardiovascular mortality with androgen deprivation therapy in prostate cancer: A secondary analysis of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Randomized Controlled Trial. Cancer 127 (13) (2021)
Brandon A Mahal, Mohammed Alshalalfa, Shuang G Zhao, Himisha Beltran, William S Chen, Fallon Chipidza, Elai Davicioni, R Jeffrey Karnes, Sheng-Yu Ku, Tamara L Lotan, Vinayak Muralidhar, Timothy R Rebbeck, Edward M Schaeffer, Daniel E Spratt, Felix Y Feng, Paul L Nguyen
Genomic and clinical characterization of stromal infiltration markers in prostate cancer. Cancer 126 (7) (2020)
Santino S Butler, Edward Christopher Dee, Nayan Lamba, Sybil T Sha, Brandon A Mahal, Amanda Whitbeck, Rishi Makkar, Janet Wangoe, Kent W Mouw, Paul L Nguyen, Vinayak Muralidhar
Validation of a subclassification for high-risk prostate cancer in a prospective cohort. Cancer 126 (10) (2020)
David-Dan Nguyen, Quoc-Dien Trinh, Alexander P Cole, Kerry L Kilbridge, Brandon A Mahal, Matt Hayn, Moritz Hansen, Paul K J Han, Jesse D Sammon
Impact of health literacy on shared decision making for prostate-specific antigen screening in the United States. Cancer 127 (2) (2020)
Brandon A Mahal
Fusion-guided biopsy to guide active surveillance in African-American men? BJU international 124 (5) (2020)
Edward Christopher Dee, Michelle D Nezolosky, Fallon E Chipidza, Melaku A Arega, Santino S Butler, Sybil T Sha, Brandon A Mahal, Paul L Nguyen, David D Yang, Vinayak Muralidhar
Prostate cancer-specific mortality burden by risk group among men with localized disease: Implications for research and clinical trial priorities. The Prostate 80 (13) (2020)
Santino S Butler, Brandon A Mahal
Reply to Obesity and aggressive prostate cancer and the golden rule: Do not do to others what you do not want done to yourself. Cancer 126 (10) (2020)
Zoe H Fullerton, Santino S Butler, Brandon A Mahal, Vinayak Muralidhar, Jonathan D Schoenfeld, Roy B Tishler, Danielle N Margalit
Short-term mortality risks among patients with oropharynx cancer by human papillomavirus status. Cancer 126 (7) (2020)
Nina Niu Sanford, David J Sher, Santino S Butler, Xiaohan Xu, Chul Ahn, Ayal A Aizer, Brandon A Mahal
Prevalence of chronic pain among cancer survivors in the United States, 2010-2017. Cancer 125 (23) (2019)
Santino S Butler, Vinayak Muralidhar, Shuang G Zhao, Nina N Sanford, Idalid Franco, Zoe H Fullerton, Janice Chavez, Anthony V D'Amico, Felix Y Feng, Timothy R Rebbeck, Paul L Nguyen, Brandon A Mahal
Prostate cancer incidence across stage, NCCN risk groups, and age before and after USPSTF Grade D recommendations against prostate-specific antigen screening in 2012. Cancer 126 (4) (2019)
Santino S Butler, Brandon A Mahal, Nayan Lamba, Matthew Mossanen, Neil E Martin, Kent W Mouw, Paul L Nguyen, Vinayak Muralidhar
Use and early mortality outcomes of active surveillance in patients with intermediate-risk prostate cancer. Cancer 125 (18) (2019)
Amandeep R Mahal, Santino S Butler, Idalid Franco, Vinayak Muralidhar, Dalia Larios, Luke R G Pike, Shuang G Zhao, Nina N Sanford, Robert T Dess, Felix Y Feng, Anthony V D'Amico, Daniel E Spratt, James B Yu, Paul L Nguyen, Timothy R Rebbeck, Brandon A Mahal
Conservative management of low-risk prostate cancer among young versus older men in the United States: Trends and outcomes from a novel national database. Cancer 125 (19) (2019)
Brandon A Mahal, Yu-Wei Chen, Roshan V Sethi, Oscar A Padilla, David D Yang, Janice Chavez, Vinayak Muralidhar, Jim C Hu, Felix Y Feng, Karen E Hoffman, Neil E Martin, Daniel E Spratt, James B Yu, Peter F Orio, Paul L Nguyen
Travel distance and stereotactic body radiotherapy for localized prostate cancer. Cancer 124 (6) (2017)